우리나라 대사증후군의 유병률

1) 통계청. 2001년 사망원인통계결과. 2002. www.nso.go.kr
2) Isomaa B, Almgren P, Tuomi T, Forsen B, Lahti K, Nissen M, Taskinen MR, Groop L. Cardiovascular morbidity and mortality associated with the metabolic syndrome. Diabetes Care 2001;24:683-9
3) Lakka H, Laadsonen DE, Lakka TA, Niskanen LD, Kumpusalo E, Tuomilehto J, Salonen JT. The metabolic syndrome and total cardiovascular disease mortality in middle-aged men. JAMA 2002;288:2709-16
4) 박혜순, 김영식, 박성욱, 박승정. 심혈관 위험인자의 군집 현상과 관상동맥질환과의 관 계. 가정의학회지 1998;19:881-93
5) Alberti KG. Zimmet PZ. Definition, diagnosis and classification of diabetes mellitus and its complications. Part 1: diagnosis and Classification of diabetes mellitus provisional report of a WHO consultation. Diabetic Med 1998;15(7):539-53
6) Balkau B. Charles MA. Comment on the provisional report from the WHO consultation. European Group for the Study of Insulin Resistance(EGIR) Diabetic Med 1999;16(5):442-3
7) Reaven GM. Banting lecture 1998. Role of insulin resistance in human disease. Diabetes 1988;37:1595-607.
8) Hjermann I. The metabolic cardiovascular syndrome: syndrome X, Reaven`s syndrome, insulin resistance syndrome, atherothrombogenic syndrome. J Cardiovasc Pharmacol 1992;20:S5-S10
9) Executive Summary of The Third Report of The National Cholesterol Education Program(NCEP) Expert Panel on Detection, Evaluation, And Treatment of High Blood Cholesterol in Adults(Adult Treatment PanelⅢ). JAMA 2001;285:2486-97
10) Ford ES, Giles WH, Dietz WH. Prevalence of the metabolic syndrome among US adults: findings from the third National Health and Nutrition Examination Survey. JAMA 2002;287:356-9
11) 보건복지부. 95 국민영양조사. 1997
12) 보건복지부. 98 국민건강영양조사, 건강검진조사. 1999
13) Wilson PWF, Kannel WB, Silbershatz H, D`Agostino RB. Clustering of metabolic factors and coronary heart disease. Arch intern Med. 1999;159:1104-9
14) Vague J. The degree of masculine differentiation of obesities: a factor determining predisposition to diabetes, atherosclerosis, gout and uric calculous desease. American Journal of Clinical Nutrition. 1956;4:615-22
15) Fujimoto WY, Bergstrom RW, Boyko EJ, Leonetti DL, Newell-Morris LL, Wahl PW. Susceptibility to development of Central adiposity among populations. Obes Res 1995;3(Suppl.2):S179-S86
16) McKeigue PM, Shah B, Marmot MG. Relation of central obesity and insulin resistance with high diabetes prevalence and cardiovascular risk in South Asians. Lancet 1991;337:382-6
17) 박정식, 박현덕, 윤중원, 정찬회, 이원영, 김선우. 도시지역 검진수검자 40,698명에서 NCEP-ATP Ⅲ 기준에 의한 대사증후군의 유병률. 대한내과학회지 2002;63:290-8
18) 정혜원, 김대중, 김하동, 최성희, 안철우, 차봉수, 이현철, 허갑범. 새로운 비만기준에 따른 대사증후군의 유병률. 당뇨병2001;26:431-42
19) 보건복지부. 98 국민건강영양조사; 보건의식행태조사. 1999
20) International Obesity Task Force. The Asia-Pacific perspective: redefining obesity and its treatment. Western Pacific Region. 2000
21) 통계청. 1998년 추계인구. 1999. www.stst.go.kr
22) 박혜순, 오상우 등. 한국인에서 대사성증후군의 유병률 및 관련 요인 - 1998년 국민영양건강조사를 바탕으로 - 대한비만학회지 2003;12(1):1-14
23) 박정식, 박현덕, 윤중원, 정찬희, 이원영, 김선우. 도시지역 검진수진자 40,698명에서 NCEP-ATP III 기준에 의한 대사증후군의 유병률. 대한내과학회지 2002;63(3):290-298
24) Flegal KM. Carroll MD. Kuczmarski RJ. Johnson CL. Overweight and obesity in the United States: prevalence and trends, 1960-1994
25) American Stroke Association / American Heart Association. Heart disease and Stroke Statistics; 2003 update.